Development of benzofuran-based 1,3,4-oxadiazole hybrids as potential BRD4 inhibitors and antidiabetic activities

Authors: Ugur Uzuner, Samet İzgi, Selcen Celik-Uzuner et al.
Publication: Journal of Molecular Structure
Published: Oct 1, 2026
Source: Crossref
Back to Search View Original Cite This Article

Related Articles

A Simplified Approach to Evaluate Retinal Blue Light Hazard Using the Correlated Color Temperature of LED Light Sources

Farough Mohammadian, Ahmad Mehri et al. - Oct 2121

Read More
The Development of Loyalty with Online Services Customers

Apostolos Giovanis - Jan 2117

Read More
Corporate Social Responsibility: A marketing tool and/or a factor for the promotion of sustainable development for companies? An empirical examination of listed companies in the Athens Stock Exchange

Olga Helen Astara, Roldo Mitoula et al. - Apr 2115

Read More
Different or alike? Comparing computer-based and paper-based card sorting

Greve Goetz - Dec 2114

Read More
WEB-BASED COLLABORATIVE LEARNING AND KNOWLEDGE SHARING IN INFORMAL BUSINESS NETWORKS

George Stalidis, Costis Papadimitrakopoulos et al. - Dec 2114

Read More
Journal Ideas PyMinds Charcha More
PORE

About

About Us

Resources

Help Centre Research Guides CiteScore

Legal

Terms of Service Privacy Policy Cookie Policy Accessibility

Connect

Contact Us
© 2026 PORE. Content available under CC BY-NC 4.0